Notícias e Atividades da Qualigen Therapeutics

Qualigen Therapeutics é uma empresa listada sob o símbolo QLGN (US).

Eles estão dentro:

• Equipamentos Médicos50%
• Biotecnologia50%

Veja o organograma con seus 12 executivos principais

Biografias mais buscadas da Qualigen Therapeutics

• Kevin Richardson, Interim Chief Executive Officer and Chief Financ...
• Graydon Bensler, Director
• Braeden Lichti, Director

Criar um alerta
para seguir os movimentos de executivos da Qualigen Therapeutics.

Qualigen Therapeutics possui 1.250 concorrentes concorrentes Thermo Fisher Scientific (Estados Unidos), Cytiva (Estados Unidos) e Siemens Healthineers (Alemanha).

Popular M&A news in Equipamentos Médicos

• Think Surgical acaba de anunciar uma arrecadação de fundos de 65 milhões de dólares. (publicado em 16 de julho de 2026).
• Pearl Health acaba de anunciar uma arrecadação de fundos de 110 milhões de dólares. (publicado em 12 de julho de 2026).
• EQT has announced the acquisition of Corza Medical  (publicado em 9 de julho de 2026).

Outros contatos sugeridos na indústria do Equipamentos Médicos

• Ivan Tornos - Chairman, President and Chief Executive Officer da Zimmer Biomet
• Kevin Lobo - President, Chief Executive Office & Chairman of the Board da Stryker
• Marc Casper - Chairman of the Board, President and Chief Executive Officer da Thermo Fisher Scientific

Saiba mais sobre a indústria do Equipamentos Médicos

Últimos comunicados de imprensa de Qualigen Therapeutics

• Media & Events – Qualigen Therapeutics IR Media & Events – Qualigen Therapeutics IR
• University of Louisville working on potential breakthrough COVID-19 treatment | Fox News Video
• Qualigen Therapeutics, Inc. to present at the Benzinga Biotech Small Cap Conference :: Qualigen Therapeutics, Inc. (QLGN)
• Qualigen Therapeutics, Inc. Promotes Shishir Sinha to Chief Operating Officer Position :: Qualigen Therapeutics, Inc. (QLGN)
• Qualigen Therapeutics, Inc. to present at the Oppenheimer 31st Annual Healthcare Conference :: Qualigen Therapeutics, Inc. (QLGN)
• Qualigen Therapeutics Secures Option to Negotiate License for G-Quadruplex Anti-Cancer Technology from UCL :: Qualigen Therapeutics, Inc. (QLGN)
• Qualigen Therapeutics Announces Completion of Milestone Related to the License and Technology Transfer of its FastPack® Diagnostics Products in China :: Qualigen Therapeutics, Inc. (QLGN)
• Qualigen Therapeutics to Present at the H.C. Wainwright BioConnect 2021 Conference :: Qualigen Therapeutics, Inc. (QLGN)
• Qualigen Therapeutics Issues CEO Letter to Stockholders with 2021 Outlook :: Qualigen Therapeutics, Inc. (QLGN)
• Qualigen Therapeutics, Inc. Announces Closing of $12 Million Registered Direct Offering :: Qualigen Therapeutics, Inc. (QLGN)
• View more press releases Close

Redes sociais sobre Qualigen Therapeutics

• Qualigen Therapeutics na Wikipedia, Google News e Yahoo Finance
• Qualigen Therapeutics na LinkedIn, X (Twitter) e YouTube